Press Release: Pmc Biogenix : PMC Biogenix Announces Price Increase on Armoslip and Kemamide Fatty Amides

MEMPHIS, Tenn.--(BUSINESS WIRE)--PMC Biogenix Inc. announces that effective February 1, 2015 or as contracts permit, prices for Armoslip and Kemamide brand primary and secondary fatty amides and bisamides will increase.